quinacrine has been researched along with Active Hyperemia in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nuttle, LC | 1 |
| Ligon, AL | 1 |
| Farrell, KR | 1 |
| Hester, RL | 1 |
| Kimura, T | 1 |
| Satoh, S | 1 |
2 other studies available for quinacrine and Active Hyperemia
| Article | Year |
|---|---|
Inhibition of phospholipase A2 attenuates functional hyperemia in the hamster cremaster muscle.
Topics: Adenosine; Animals; Arachidonic Acid; Arterioles; Cricetinae; Enzyme Inhibitors; Hyperemia; Male; Me | 1999 |
Inhibitory effect of quinacrine on myocardial reactive hyperemia in the dog.
Topics: Acetylcholine; Adenosine; Animals; Blood Flow Velocity; Catechols; Coronary Circulation; Dogs; Femal | 1985 |